Picture of Davita logo

DVA — Davita News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapSuper Stock

DaVita Inc reports results for the quarter ended September 30 - Earnings Summary

DaVita Inc reports results for the quarter ended September 30 - Earnings Summary
  • DaVita Inc DVA.N reported quarterly adjusted earnings of $3.40​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of $2.04. The mean expectation of seven analysts for the quarter was for earnings of $3.61 per share. Wall Street expected results to range from $3.41 to $4.03 per share.

  • Revenue rose 4.6% to $3.58 billion from a year ago; analysts expected $3.51 billion.

  • DaVita Inc's reported EPS for the quarter was $3.40​.

  • The company reported quarterly net income of $222.93 million.

  • DaVita Inc shares had risen by 5.2% this quarter and gained 61.9% so far this year.

FORECAST CHANGES

  • The mean earnings estimate of analysts had fallen by about 8% in the last three months.​

  • In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 4 "strong buy" or "buy," 4 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the healthcare facilities & services peer group is "buy."

  • Wall Street's median 12-month price target for DaVita Inc is $220.00, about 12.1% above its last closing price of $193.31

This summary was machine generated from LSEG data October 29 at 10:30 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING

ESTIMATE

ACTUAL

BEAT, MET, MISSED

Sep. 30 2026

3.61

3.40

Missed

Jun. 30 2026

3.88

4.02

Beat

Mar. 31 2026

2.32

2.87

Beat

Dec. 31 2025

3.16

3.40

Beat

Recent news on Davita

See all news